RU CHEN to Adenocarcinoma
This is a "connection" page, showing publications RU CHEN has written about Adenocarcinoma.
Connection Strength
0.474
-
Proteome alterations in pancreatic ductal adenocarcinoma. Cancer Lett. 2020 01 28; 469:429-436.
Score: 0.193
-
Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma. Lab Invest. 2015 Jan; 95(1):43-55.
Score: 0.136
-
Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions. Radiology. 2015 Dec; 277(3):644-61.
Score: 0.037
-
Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Gastroenterology. 2013 Oct; 145(4):885-894.e3.
Score: 0.031
-
Quantitative proteomics investigation of pancreatic intraepithelial neoplasia. Electrophoresis. 2009 Apr; 30(7):1132-44.
Score: 0.023
-
Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med. 2006 Dec; 3(12):e516.
Score: 0.020
-
Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer. Proteomics Clin Appl. 2017 09; 11(9-10).
Score: 0.010
-
Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res. 1995 Oct 01; 55(19):4264-7.
Score: 0.009
-
Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. J Med Genet. 1995 May; 32(5):330-5.
Score: 0.009
-
Proteomics portrait of archival lesions of chronic pancreatitis. PLoS One. 2011; 6(11):e27574.
Score: 0.007